ARCHIVES

NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units

This article is from The Cancer Letter archive.

Vol. 39 No. 09 | March 1, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002

Surgeon General Issues Call To Reduce Skin Cancer Rates

August 1, 2014

NCI Programs: NCI To Study Colorectal Cancer Screening Practices

September 17, 1999

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001